Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Schedule of Disaggregation of Revenue

Revenue is disaggregated by primary geographical market, major product line, and timing of revenue recognition.

In thousands	Year Ended December 31, 2025
Products By Geographic Area	Total		U.S.		Rest of World
License Fee – Over Time	$	325	$	—	$	325
Concentrate Product Sales - Point-in-Time	68,933		60,358		8,575
Net Revenue	$	69,258	$	60,358	$	8,900
In thousands	Year Ended December 31, 2024
Products By Geographic Area	Total		U.S.		Rest of World
License Fee – Over Time	$	46	$	—	$	46
Concentrate Product Sales - Point-in-Time	101,443		92,258		9,185
Net Revenue	$	101,489	$	92,258	$	9,231

Schedule of Contract Balances

The following table provides information about receivables, contract assets, and contract liabilities from contracts with customers.

In thousands	December 31, 2025		December 31, 2024		January 1, 2024
Accounts Receivable, net	$	8,143	$	8,291	$	10,901
Contract Liabilities, which are included in deferred license revenue	$	—	$	475	$	521

Schedule of Potentially Dilutive Securities

The following table includes the potential shares of common stock that were excluded from the computation of diluted EPS per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

	As of December 31,
	2025	2024
Warrants to Purchase Common Stock	3,984,484	3,984,484
Options to Purchase Common Stock	3,276,564	1,886,247
Convertible Preferred Stock	1,405,001	1,391,045
Unvested Restricted Stock Units	1,156,660	584,309
Unvested Restricted Stock Units - Market Condition	717,000	—
Unvested Restricted Stock Awards	891	891
Total	10,540,600	7,846,976

Schedule of Basic and Diluted Net Loss Per Share

The following table presents the calculation of basic and diluted EPS:

	Years Ended December 31,
	2025		2024
Numerator:
Net Loss	$	(5,314)	$	(480)
Accretion of Series X Preferred Stock	(153)		(302)
Net Loss Attributable to Common Stockholders	$	(5,467)	$	(782)
Denominator
Weighted Average Number of Shares of Common Stock Outstanding - Basic and Diluted	35,974,231		31,058,539
Net Loss Per Share Attributable to Common Stockholders - Basic and Diluted	$	(0.15)	$	(0.03)